Cellules de Langerhans et présentation d'antigènesHANAU, D; ESPOSITO-FARESE, M.-E; DE LA SALLE, H et al.Pathologie et biologie. 1992, Vol 40, Num 2, pp 109-113, issn 0369-8114Article

Critical sequences within mitochondrial introns: pleiotropic mRNA maturase and cis-dominant signals of the box intron controlling reductase and oxidaseDE LA SALLE, H; JACQ, C; SLONIMSKI, P. P et al.Cell (Cambridge). 1982, Vol 28, Num 4, pp 721-732, issn 0092-8674Article

ROAD TRAFFIC NOISE AND CARDIOVASCULAR DISEASE. A POPULATION STUDY IN THE NETHERLANDSKNIPSCHILD P; SALLE H.1979; INTERNATION. ARCH. OCCUP. ENVIRONMENT. HEALTH; DEU; DA. 1979; VOL. 44; NO 1; PP. 55-59; BIBL. 9 REF.Article

Clinical and immunological aspects of HLA class I deficiencyZIMMER, J; ANDRES, E; DONATO, L et al.QJM (Oxford. 1994. Print). 2005, Vol 98, Num 10, pp 719-727, issn 1460-2725, 9 p.Article

Expression of the high-affinity receptor for IgE (FcεRI) on human Langerhans cells : the end of a dogmaBIEBER, T; DE LA SALLE, H; DE LA SALLE, C et al.Journal of investigative dermatology. 1992, Vol 99, Num 5, pp 10S-11S, issn 0022-202XConference Paper

Déficit en antigènes d'histocompatibilité de classe I et transporteur de peptides = TAP peptide transporter mutation in human HLA class I deficiencyDE LA SALLE, H; HANAU, D; TONGIO, M.-M et al.MS. Médecine sciences. 1994, Vol 10, Num 12, pp 1312-1314, issn 0767-0974Article

Physical map of the vitopine Ti plasmid pTiS4GERARD, J.-C; CANADAY, J; SZEGEDI, E et al.Plasmid (Print). 1992, Vol 28, Num 2, pp 146-156, issn 0147-619XArticle

Human keratinocytes release to endogenous β-galactoside-binding soluble lectin immunoglobulin E (IgE-binding protein) which binds to Langerhans cell where it modulates their binding capacity for IgE glycoformsWOLLENBERG, A; DE LA SALLE, H; HANAU, D et al.The Journal of experimental medicine. 1993, Vol 178, Num 3, pp 777-785, issn 0022-1007Article

AIRCRAFT NOISE AND BIRTH WEIGHTKNIPSCHILD P; MEIJER H; SALLE H et al.1981; INT. ARCH. OCCUP. ENVIRON. HEALTH; ISSN 0340-0131; DEU; DA. 1981; VOL. 48; NO 2; PP. 131-136; BIBL. 13 REF.Article

Fate of MHC class II molecules in human dendritic cellsHANAU, D; SAUDRAIS, C; HAEGEL-KRONENBERGE, H et al.EJD. European journal of dermatology. 1999, Vol 9, Num 1, pp 7-12, issn 1167-1122Article

Carrier detection of hemophilia B by using a restriction site polymorphism associated with the coagulation factor IX geneGRUNEBAUM, L; CAZENAVE, J.-P; CAMERINO, G et al.The Journal of clinical investigation. 1984, Vol 73, Num 5, pp 1491-1495, issn 0021-9738Article

Human epidermal Langerhans cells secrete a soluble receptor for IgG (FcγRII/CD32) that inhibits the binding of immune complexes to FcγR⁺ cellsASTIER, A; DE LA SALLE, H; DE LA SALLE, C et al.The Journal of immunology (1950). 1994, Vol 152, Num 1, pp 201-212, issn 0022-1767Article

Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assayASTIER, A; DE LA SALLE, H; MONCUIT, J et al.Journal of immunological methods. 1993, Vol 166, Num 1, pp 1-10, issn 0022-1759Article

Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vectorBALLAND, A; FAURE, T; CARVALLO, D et al.European journal of biochemistry (Print). 1988, Vol 172, Num 3, pp 565-572, issn 0014-2956Article

Antigen-presenting cells and tolerance inductionVON BUBNOFF, D; DE LA SALLE, H; WESSENDORF, J et al.Allergy (Copenhagen). 2002, Vol 57, Num 1, pp 2-8, issn 0105-4538Article

Release of FcγRIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant FcγRIIa2GACHET, C; ASTIER, A; DE LA SALLE, H et al.Blood. 1995, Vol 85, Num 3, pp 698-704, issn 0006-4971Article

Release of soluble FcγRII/CD32 molecules by human Langerhans cells : a subtle balance between shedding and secretion ?DE LA SALLE, C; ESPOSITO-FARESE, M.-E; HANAU, D et al.Journal of investigative dermatology. 1992, Vol 99, Num 5, pp 15S-17S, issn 0022-202XConference Paper

Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII Δ IISIVADASAN KRISHNAN; KOLBE, H. V. J; MEULIEN, P et al.European journal of biochemistry (Print). 1991, Vol 195, Num 3, pp 637-644, issn 0014-2956, 8 p.Article

Comparison of five methods for measurement of vibratory perceptionSALLÉ, H. J. A; VERBERK, M. M.International archives of occupational and environmental health. 1984, Vol 53, Num 4, pp 303-309, issn 0340-0131Article

Vibratory and tactile sense of the fingers after working with sandersVERBERK, M. M; SALLE, H. J. A; KEMPERS, O et al.International archives of occupational and environmental health. 1985, Vol 56, Num 3, pp 217-223, issn 0340-0131Article

Tremor, effect of physical load and reproducibilitySALLE, H. J. A; VERBERK, M. M; KEMPER, C. M et al.American Industrial Hygiene Association journal. 1986, Vol 47, Num 9, pp 563-566, issn 0002-8894Article

Tremor in workers with low exposure to metallic mercuryVERBERK, M. M; SALLE, H. J. A; KEMPER, C. H et al.American Industrial Hygiene Association journal. 1986, Vol 47, Num 9, pp 559-562, issn 0002-8894Article

Tremor, effect of physical load and reproducibilitySALLE, H. J. A; VERBERK, M. M; KEMPER, C. M et al.American Industrial Hygiene Association journal. 1986, Vol 47, Num 9, pp 563-566, issn 0002-8894Article

Comparison of two techniques to measure the motor nerve refractory period distributionRUIJTEN, M. W. M. M; SALLE, H. J. A; KINGMA, R et al.Electroencephalography and clinical neurophysiology. Electromyography and motor control. 1994, Vol 93, Num 4, pp 299-305, issn 0924-980XArticle

Verification of effects on the nervous system of low level occupational exposure to CS₂RUIJTEN, M. W. M. M; SALLE, H. J. A; VERBERK, M. M et al.British journal of industrial medicine. 1993, Vol 50, Num 4, pp 301-307, issn 0007-1072Article